| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/23/2004 | CN1506363A Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506096A Cold treating medicine composition containing phytic acid |
| 06/23/2004 | CN1506095A Cold-treating medicine containing Dexamethasone acetate |
| 06/23/2004 | CN1506093A Elsholizia extract prepn and its quality control method and new use |
| 06/23/2004 | CN1506089A Cold-treatig medicine composition containing pyroglutamic acid |
| 06/23/2004 | CN1506088A Cold-treating medicine containing chlorpheniramine |
| 06/23/2004 | CN1506078A Prepn of dispersive Yinhuang tablet |
| 06/23/2004 | CN1506074A Jiaoqijing medicine for treating beriberi and its prepn |
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154732C Synthetic HPV6/11 hybrid Li DNA encoding human papliomavirus type 11 L1 protein |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154660C Hybrid molecules between heat-labile enterotoxin and cholera toxic B subunits |
| 06/23/2004 | CN1154659C Novel anti-AIDS immunotoxins |
| 06/23/2004 | CN1154649C Novel C-2 5/0-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta lactamase inhibitors |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154645C S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 06/23/2004 | CN1154644C Oxazolidinone derivatives and pharmaceutical compositions |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/23/2004 | CN1154509C Multivalent vaccine compsn. with mixed carrier |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154503C Antimycotic antidiarrheal |
| 06/23/2004 | CN1154500C Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition |
| 06/23/2004 | CN1154493C Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antivirual agents containing both |
| 06/23/2004 | CN1154491C Method for improving pharmacokinetics of tipranavir |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/22/2004 | US6753451 Reacting keto compound, 1,3-dioxolane, and an ammonium halide to yield a b-aminoketone; reacting with n-acetylmethylpyridinium halide; friedel-crafts alkylation |
| 06/22/2004 | US6753445 14-o-((cycloalkyl-sulfanyl)acetyl)-, 14-o-((cycloalkyl-alkyl-sulfanyl)acetyl)-, 14-o-((cycloalkoxy)acetyl)- and 14-o-((cycloalkyl-alkoxy) acetyl) mutilins; microbiocides |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753427 2,6-disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease |
| 06/22/2004 | US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 06/22/2004 | US6753415 Bactericides against grampositive and gramnegative bacteria and macrolide resistant bacteria |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753015 Microparticle compositions and methods for the manufacture thereof |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/22/2004 | CA2114113C Cardiac output probe assembly |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050677A1 Novel chemical compunds and their use |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050638A1 Antibacterial agents |
| 06/17/2004 | WO2004050120A2 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 06/17/2004 | WO2004050118A1 Cysteine protease inhibitor |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050101A2 Formulations useful against hepatitis c virus infections |
| 06/17/2004 | WO2004050096A2 Phosphoantigens for regulating an immune response |
| 06/17/2004 | WO2004050095A1 Use of a known substance for the treatment of cancer and bacterial and fungal infections |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050081A1 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004032911A3 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003099110A3 Herbs and herbal combinations useful for the treatment of microbial infections |
| 06/17/2004 | WO2003097050A3 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 06/17/2004 | WO2003064992A3 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003028700A3 Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 06/17/2004 | WO2003015689A3 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116690 Lincomycin derivatives possessing antibacterial activity |
| 06/17/2004 | US20040116665 Vaccine composition |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116655 Viricides |
| 06/17/2004 | US20040116653 Compositions containing anti-HIV peptides and methods for use |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116636 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 06/17/2004 | US20040116523 Use of c4-c10 acids for preventing gram-negative bacterial infections |
| 06/17/2004 | US20040116521 Prophylaxis of fungal infections using mixtures of 2-chloroethanesulfonic acid and salts, water and adjuvants such as buffers, stabilizer agents, flavors or preservatives |
| 06/17/2004 | US20040116509 Antiviral agent; reducing the activity of viral polymerase; 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid for example |
| 06/17/2004 | US20040116501 Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116493 Anti-helicobacterial agents |
| 06/17/2004 | US20040116485 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116464 N-(4-chlorobenzyl)-2-((((2S)-2-hydroxy-2-(4-hydroxyphenyl)ethyl)(methyl)amino)methyl)-7-methyl-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamide; for treating and preventing herpes viral infections |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116452 Aminipiperidine compound; bactericides |
| 06/17/2004 | US20040116448 Substances for the therapy of diseases caused by highly proliferating cells |
| 06/17/2004 | US20040116441 Antagonist as immunomodulators for cardiovascular disorders, antiinflammatory agents and treatment of other conditions |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116428 Biguanide and dihydrotriazine derivatives |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116420 Remedial agent for viral infectious disease |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116413 useful against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci and streptococci, anaerobic organisms such as bacteroides and clostridia species, and acid-fast organisms |
| 06/17/2004 | US20040116411 and at least one antiretroviral drug, such as nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors and integrase inhibitors |
| 06/17/2004 | US20040116380 enhance a host's immune defense mechanisms to infection but do not induce an inflammatory response |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |